Article
Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay
3 Sept 2019
Abstract excerpt
X-linked Alport syndrome (XLAS) is a congenital renal disease caused by mutations in COL4A5. In XLAS cases suspected of being caused by aberrant splicing, transcript analysis needs to be conducted to determine splicing patterns and assess the pathogenicity. However, such analysis is not always available. We conducted a functional splicing assay using a hybrid minigene for seven COL4A5 intronic mutations: one was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
